Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 6,550.00
-450.00 (-6.43%)
At close: Jun 18, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 81.04 billion as of June 18, 2026. Its market cap has decreased by -8.21% in one year.
Market Cap
81.04B
Enterprise Value
65.70B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6,550.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 81.04B, a decrease of -28.14%. That is a compound annual growth rate of -10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 81.04B | -33.33% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 91.63B |
| KOREA PHARMA | 91.40B |
| Samik Pharmaceutical Company LTD. | 84.16B |
| Sam-A Pharm. | 81.36B |
| Daehan Nupharm | 79.58B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Sinsin Pharmaceutical | 68.42B |